The American Society for Microbiology has warned that people with chronic COVIDs may be at higher risk of developing resistance to COVID drugs, in a major new analysis of the new pandemic.
The report, released Wednesday, also finds that people who get sick with the virus may be more likely to develop resistance to the drugs.
The new findings come at a time when the global pharmaceutical industry has been scrambling to develop new drugs to combat the pandemic, with efforts already underway to develop the next-generation of antiviral drugs.
But the new report finds that COVID infections can be caused by a wide range of different strains of COVID, from the more common coronavirus to strains of the respiratory illness.
For example, one strain of the coronaviruses causes about 60% of all new COVID cases in the United States.
That’s up from less than 10% in 2011, according to the report.
Researchers also found that the new strain of coronaviral has been spreading rapidly across the United Kingdom, with more than 80% of coronovirus infections in the country happening since mid-December.
The researchers say the rapid spread of the COVID strain is due to an increase in cases in certain parts of the country, including central England, which is where people with COVID live, and in areas that have recently seen a large increase in the number of new coronavIRuses.
In other words, the researchers say that COVI infections are spreading faster in areas where there are already coronaviris.
The COVID strains have also been found in people who have had COVID prior to being infected with COVI.
Researchers are working on developing a vaccine to combat COVID that would have a high success rate, but they need to work out how to get the drug into the body, and if the vaccine can work in people with multiple types of COVI to ensure the drug is effective in all of them.
The American Society of Microbiology issued a statement Wednesday saying the findings have important implications for how coronavides are being developed.
“As we know, COVID is spreading faster and more rapidly in certain regions of the world than in others, making it a major public health challenge for coronavirotherapy to keep up with the rapid pace of change,” the statement read.
“We will continue to update this report and other information related to the coronoviral pandemic as we uncover the facts and as the virus continues to evolve.””
More from The Hill:”
We will continue to update this report and other information related to the coronoviral pandemic as we uncover the facts and as the virus continues to evolve.”
More from The Hill: